Skip to main content

Angion Biomedica Corp. Common Stock (ANGN)

About The Company

ANGN Stock Market Logo

Angion Biomedica Corp is a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases. Its product candidate, ANG-3777, is a hepatocyte growth factor (HGF) mimetic that is evaluating in multiple acute organ injuries and related indications, including acute kidney injury (AKI) and injuries to other major organs, such as the lungs, central nervous system (CNS) and heart; acute lung injury (ALI), with primary focus on acute respiratory distress syndrome (ARDS), and acute CNS injuries. It is advancing multiple programs for the treatment of fibrotic diseases, leading with ANG-3070, a tyrosine kinase inhibitor (TKI), and inhibitor of rho kinase 2 (ROCK2).

IPO Year Sector Industry
2021 Health Care Biotechnology: Pharmaceutical Preparations

Angion Biomedica Corp. (ANGN) Latest News

Company Contact & Address (ANGN)

Corporate Headquarters Phone Website
New York,
United States
+1 415 655-4899 Official ANGN Website

ANGN Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ ANGN

Jobs & Employment at Angion Biomedica Corp.

LinkedIn Company Page
Official Career & Employment Page Employment, Jobs & Careers at Angion Biomedica Corp. (ANGN)

Related & Similar Stock Symbols

ACV Stock Market Price & News


Virtus AllianzGI Diversified Income & Convertible Fund Common …

TRTN^D Stock Market Price & News


Triton International Limited 6.875% Series D Cumulative Redeemable …

FTAI Stock Market Price & News


Fortress Transportation and Infrastructure Investors LLC Class …